119 related articles for article (PubMed ID: 12833018)
21. Clostridium septicum myonecrosis in congenital neutropenia.
Barnes C; Gerstle JT; Freedman MH; Carcao MD
Pediatrics; 2004 Dec; 114(6):e757-60. PubMed ID: 15574607
[TBL] [Abstract][Full Text] [Related]
22. Advances in the use of colony-stimulating factors for chemotherapy-induced neutropenia.
Dale DC
J Support Oncol; 2005; 3(2 Suppl 1):39-41. PubMed ID: 15794500
[No Abstract] [Full Text] [Related]
23. Thymic alymphoplasia with hyper-IgE-globulinemia.
Kikkawa Y; Kamimura K; Hamajima T; Sekiguchi T; Kawai T
Pediatrics; 1973 Apr; 51(4):690-6. PubMed ID: 4572544
[No Abstract] [Full Text] [Related]
24. Multiple periungual pyogenic granulomas following systemic 5-fluorouracil.
Curr N; Saunders H; Murugasu A; Cooray P; Schwarz M; Gin D
Australas J Dermatol; 2006 May; 47(2):130-3. PubMed ID: 16637811
[TBL] [Abstract][Full Text] [Related]
25. [Primary immunodeficiency with hyper-IgM associated with polyclonal IgM cryoprecipitation in an adult female].
Fujii H; Maekawa T; Kanoh T; Ohno T; Urata Y
Nihon Ketsueki Gakkai Zasshi; 1987 Aug; 50(5):1014-23. PubMed ID: 3434140
[No Abstract] [Full Text] [Related]
26. Weekly epirubicin and paclitaxel with granulocyte colony-stimulating factor support in previously untreated metastatic breast cancer patients: a phase II study.
Nisticò C; Bria E; Cuppone F; Fornier M; Sperduti I; Carpino A; Pace A; Cognetti F; Terzoli E
Anticancer Drugs; 2007 Jul; 18(6):687-92. PubMed ID: 17762397
[TBL] [Abstract][Full Text] [Related]
27. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients.
Winkelstein JA; Marino MC; Ochs H; Fuleihan R; Scholl PR; Geha R; Stiehm ER; Conley ME
Medicine (Baltimore); 2003 Nov; 82(6):373-84. PubMed ID: 14663287
[TBL] [Abstract][Full Text] [Related]
28. Novel strategies for granulocyte colony-stimulating factor treatment of severe prolonged neutropenia suggested by mathematical modeling.
Shochat E; Rom-Kedar V
Clin Cancer Res; 2008 Oct; 14(20):6354-63. PubMed ID: 18927273
[TBL] [Abstract][Full Text] [Related]
29. Optimal use of granulocyte-colony-stimulating factor in patients with cancer who are at risk for chemotherapy-induced neutropenia.
Cappozzo C
Oncol Nurs Forum; 2004 May; 31(3):569-76. PubMed ID: 15146222
[TBL] [Abstract][Full Text] [Related]
30. [Disseminated pyogenic granuloma induced by erythropoietin?].
Suárez-Amor O; Cabanillas M; Monteagudo B; de Las Heras C; Cacharrón JM
Actas Dermosifiliogr; 2009 Jun; 100(5):439-40. PubMed ID: 19558929
[No Abstract] [Full Text] [Related]
31. Mutation analysis and therapeutic response to granulocyte colony-stimulating factor in a case of hyperimmunoglobulin M syndrome with chronic neutropenia.
Mori M; Nonoyama S; Neubauer M; Mitsuda T; Kosuge K; Yokota S
J Pediatr Hematol Oncol; 2000; 22(3):288-9. PubMed ID: 10864066
[No Abstract] [Full Text] [Related]
32. Is granulocyte colony-stimulating factor therapy a risk factor for myelodysplasia/leukemia in patients with congenital neutropenia?
Niemeyer CM; Kratz CP
Haematologica; 2005 Jan; 90(1):2-3. PubMed ID: 15644298
[No Abstract] [Full Text] [Related]
33. Eruptive pyogenic granulomas developing after drug hypersensitivity reaction.
Palmero ML; Pope E
J Am Acad Dermatol; 2009 May; 60(5):855-7. PubMed ID: 19211171
[TBL] [Abstract][Full Text] [Related]
34. A multicenter, randomized, placebo-controlled trial of prophylactic recombinant granulocyte-colony stimulating factor in preterm neonates with neutropenia.
Kuhn P; Messer J; Paupe A; Espagne S; Kacet N; Mouchnino G; Klosowski S; Krim G; Lescure S; Le Bouedec S; Meyer P; Astruc D
J Pediatr; 2009 Sep; 155(3):324-30.e1. PubMed ID: 19467544
[TBL] [Abstract][Full Text] [Related]
35. Does granulocyte colony-stimulating factor ameliorate the proinflammatory response in human meningococcal septic shock?
Rojahn A; Brusletto B; Øvstebø R; Haug KB; Kierulf P; Brandtzaeg P
Crit Care Med; 2008 Sep; 36(9):2583-9. PubMed ID: 18679115
[TBL] [Abstract][Full Text] [Related]
36. Epulis gravidarum manum: pyogenic granuloma of the hand occurring in pregnant women.
Rader C; Piorkowski J; Bass DM; Babigian A
J Hand Surg Am; 2008 Feb; 33(2):263-5. PubMed ID: 18294552
[TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections.
Sachs UJ; Reiter A; Walter T; Bein G; Woessmann W
Transfusion; 2006 Nov; 46(11):1909-14. PubMed ID: 17076845
[TBL] [Abstract][Full Text] [Related]
38. Eczematous skin lesions in X-linked immunodeficiency with hyper-IgM.
Vieluf D; Korting HC; Belohradsky BH
Curr Probl Dermatol; 1989; 18():60-5. PubMed ID: 2743804
[No Abstract] [Full Text] [Related]
39. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
40. [Immunologic dysfunction and interstitial pulmonary fibrosis].
Belokrinitskiĭ DV; Kudriavitskiĭ AI; Kornev BM; Ovchinnikov AA; Shatalov NN
Vestn Akad Med Nauk SSSR; 1985; (11):27-32. PubMed ID: 3879058
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
